MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma
Journal of Neuro-Oncology, 06/26/2012
Baraniskin A et al. – The study provides the first evidence that CSF miRNAs have the potential as biomarkers for treatment monitoring and disease follow–up of patients with primary lymphomas of the central nervous system (PCNSL).



